The global joint reconstruction devices market size reached USD 28.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 42.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.51% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 28.7 Billion |
Market Forecast in 2033
|
USD 42.7 Billion |
Market Growth Rate 2025-2033 | 4.51% |
Joint reconstruction devices are primarily designed for restoring the movement of joints, providing them with structural support either temporarily or permanently, or aiding in tissue reconstruction. These devices are utilized separately or together with one or more implantable medical devices as a replacement in whole or part for shoulder, hip, or knee joints. Nowadays, joint disorders like osteoarthritis (OA) are widely becoming prevalent on account of sedentary lifestyles and unhealthy dietary patterns of individuals. This is positively influencing the requirement for joint reconstruction devices across the globe.
The rising geriatric population around the world represents one of the key factors stimulating the growth of the market. Moreover, the advent of advanced, emerging technologies, such as 3D printing, robotics, and augmented reality (AR), are making joint reconstruction safer, more accurate, and efficient. 3D printing is increasingly being used in creating customized bio models (replicas of patient anatomy), devices, and implants to plan and simulate complex surgical procedures. This technology facilitates joint replacements associated with infection or the failure of a previous replacement joint. Besides this, robotic-assisted surgery is emerging as an innovative method for hip and knee arthroplasty as it offers enhanced component positioning, real-time information about soft tissue tensioning and balance, and restoration of hip length and offset. This, coupled with the increasing accidental or sports-related injuries that cause broken bones and dislocations, is strengthening the growth of the market. Apart from this, there is a rise in the number of individuals requiring total ankle replacement (TAR) and tibiotalar arthrodesis (TTA) for the surgical management of ankle arthritis, which is projected to drive the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global joint reconstruction devices market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on technique, joint type and end user.
Breakup by Technique:
Breakup by Joint Type:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aesculap Inc. (B. Braun Melsungen AG), Conformis Inc., Conmed Corporation, DJO Global Inc. (Enovis Corporation), Exactech Inc., Johnson & Johnson Services Inc, Kyocera Medical Technologies Inc. (Kyocera Corporation), Medacta International SA, Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Technique, Joint Type, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Aesculap Inc. (B. Braun Melsungen AG), Conformis Inc., Conmed Corporation, DJO Global Inc. (Enovis Corporation), Exactech Inc., Johnson & Johnson Services Inc, Kyocera Medical Technologies Inc. (Kyocera Corporation), Medacta International SA, Smith & Nephew plc, Stryker Corporation and Zimmer Biomet |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global joint reconstruction devices market was valued at USD 28.7 Billion in 2024.
We expect the global joint reconstruction devices market to exhibit a CAGR of 4.51% during 2025-2033.
The growing prevalence of joint disorders, such as osteoarthritis, along with rising number of accidental or sports-related injuries that cause broken bones and dislocations, is primarily driving the global joint reconstruction devices market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of numerous elective arthroplasty surgeries for reducing the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for joint reconstruction devices.
Based on the technique, the global joint reconstruction devices market has been segregated into joint replacement, osteotomy, arthroscopy, resurfacing, arthrodesis, and others. Among these, joint replacement currently holds the largest market share.
Based on the joint type, the global joint reconstruction devices market can be bifurcated into knee, hip, shoulder, ankle, and others. Currently, knee exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global joint reconstruction devices market include Aesculap Inc. (B. Braun Melsungen AG), Conformis Inc., Conmed Corporation, DJO Global Inc. (Enovis Corporation), Exactech Inc., Johnson & Johnson Services Inc, Kyocera Medical Technologies Inc. (Kyocera Corporation), Medacta International SA, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet.